| Current Issues | |
|---|---|
EU leaders commit to more action on Rare DiseasesEU leaders commit to more action on Rare Diseases: On June 9, Health Ministers from the 27 EU Member States unanimously signed up to a series of political commitments on behalf of Europe’s rare disease patients, by adopting a Council Recommendation on a European Action in the Field of Rare Diseases1. This means that Member States have committed to creating a rare disease action plan at national level and to cooperating at a European level on this important and unmet public health priority. more | EBE’s European Business Development Conference, 24-25 JuneThe European Biopharmaceutical Enterprises (EBE) and BIO Deutschland are pleased to invite you to attend their 3rd joint European Business Development Conference on "Best Times for Good Deals? How Biotech and Pharma Could Partner Now", which will take place in Munich on 24-25 June 2009. more |
EBE calls for urgent actionOne in five of Europe's small biopharmaceutical companies facing financial difficulty Brussels, 16th March 2009 – One of Europe’s most innovative sectors is facing potential catastrophe in the current financial crisis, as many small European biopharmaceutical companies face increasing difficulties to access the funding they need to keep afloat. A new study by French research group Alcimed, on behalf of the European Biopharmaceutical Enterprises, paints a grim picture of the impact of the crisis on the sector. more | EuroBiO 2009 on 23-25 September in LilleSupported by EBE as partner, EuroBiO 2009 is structured around 4 pillars: conferences, partnering, trade fair and job fair. This format benefits all stakeholders in Research, Industry and Finance and it covers various areas including health, diagnostics, technology and products - cosmetics, chemical, environment, agrifood. more |
